Table 2 Descriptive statistics of affected systems, MDR microorganisms and antibiotic combinations used according to the University's Antimicrobial stewardship program
Parameter | n (%) |
|---|---|
System affected (n=32)* | |
Sputum | 19 (59.3%) |
Blood | 10 (31.2%) |
Urine | 3 (9.4%) |
Prevalence of MDR microorganisms (n=28)** | |
Acinetobacter MDR | 14 (50%) |
Klebsiella MDR | 12 (42.8%) |
Pseudomonas MDR | 2 (7.1%) |
Antibiotic combinations used (n=26) | |
Piperacillin Tazobactam + Colistimethate sodium | 13 (50%) |
Imipenem+ Colistimethate sodium | 9 (34.6%) |
Ceftazidime-Clindamycin –Amikacin | 1 (3.8%) |
Colistimethate sodium + Ciprofloxacin | 1 (3.8%) |
Piperacillin + Amikacin | 1 (3.8%) |
Meropenem+ Amikacin | 1 (3.8%) |